Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jan 04, 2024 | Chief People Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 2,692 | $13.44 | 276,815 | |
| Jan 04, 2023 | Chief People Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 2,692 | $12.03 | 241,073 | |
| Aug 18, 2008 | Chief Operating Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 2,700 | $15.02 | 53,749 | |
| Sep 22, 2008 | Director | Open market or private sale of non-derivative or derivative security | Form 4 | 2,726 | $16.02 | 1,760,067 | |
| Mar 05, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 2,800 | $9.66 | 851,818 | |
| Mar 05, 2008 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 2,800 | $9.66 | 851,818 | |
| Jun 27, 2007 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4/A | 2,800 | $11.36 | 69,302 | |
| Jun 27, 2007 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 2,800 | $11.36 | 69,302 | |
| Jul 01, 2015 | SVP, Chief Patient Advocate | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 2,812 | -- | 39,376 | |
| Jun 19, 2015 | SVP, Technical Operations | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 2,812 | -- | 39,376 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.